GT Biopharma Appoints Two New Independent Directors

BEVERLY HILLS, Calif., Jan. 19, 2021 -- (Healthcare Sales & Marketing Network) -- GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology company focused on innovative therapies based on the Company's proprietary NK cell engager (TriKE™) technology ... Biopharmaceuticals, Oncology, Personnel GT Biopharma, TriKE, NK cells
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news